← Leaderboards
Evan Samuel Dellon
Univ Of North Carolina Chapel Hill
$7,064,598
Attributed
$9,057,342
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,057,342 · 10
By mechanism
R01$5,800,963 · 3
P30$1,118,128 · 3
RC2$768,064 · 1
K23$541,287 · 1
R21$441,100 · 1
T35$387,800 · 1
Top collaborators
- Elizabeth T Jensen5 shared
- Anthony Thomas Blikslager1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Elizabeth T Jensen$12,211,600
- Roger D Pechous$2,751,277
- Anthony Thomas Blikslager$2,774,248
Others in their field
Top investigators on “Gastrointestinal”
- Walter John Curran · Thomas Jefferson University$113,335,296
- Norman Wolmark · Nsabp Foundation, Inc.$110,687,094
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$74,478,591
- Charles A Coltman · Southwest Oncology Group$58,629,817
- Richard L Schilsky · University Of Chicago$54,781,085
- Susan Abushakra · Alzheon, Inc.$47,690,244
Research focus
GastrointestinalEpidemiologyTranslational ResearchResponseEsophageal StenosisEosinophilic EsophagitisMultidisciplinaryInfiltrationPrevalenceMediatingEsophageal Mucous MembraneEosinophilFoodIncidenceDesignBiologyInnovationEsophagusInterestImmuneMorbidity - Disease RateFutureDigestive System DisordersFunding
Grant awards (28)
Porcine Related apprOach to Multidisciplinary cOllaborative Translational ModEl Research (PROMOTER)$768,064
RC2 · FY2025 · TR · contact PI
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis$625,444
R01 · FY2025 · ES · contact PI
Clinical Research Core$167,472
P30 · FY2025 · DK · contact PI
Short Term Research Training$135,829
T35 · FY2025 · DK · contact PI
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis$628,011
R01 · FY2024 · ES · contact PI
An allergen-specific immune signature-directed diet vs sham diet for treatment of eosinophilic esophagitis: A pilot-feasibility study$302,088
R01 · FY2024 · DK · contact PI
Biostatistics and Clinical Research Core$189,735
P30 · FY2024 · DK · contact PI
Short Term Research Training$126,833
T35 · FY2024 · DK · contact PI
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis$631,077
R01 · FY2023 · ES · contact PI
An allergen-specific immune signature-directed diet vs sham diet for treatment of eosinophilic esophagitis: A pilot-feasibility study$313,156
R01 · FY2023 · DK · contact PI
Biostatistics and Clinical Research Core$189,735
P30 · FY2023 · DK · contact PI
Short Term Research Training$125,138
T35 · FY2023 · DK · contact PI
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis$636,199
R01 · FY2022 · ES · contact PI
An allergen-specific immune signature-directed diet vs sham diet for treatment of eosinophilic esophagitis: A pilot-feasibility study$315,295
R01 · FY2022 · DK · contact PI
Biostatistics and Clinical Research Core$189,735
P30 · FY2022 · DK · contact PI
Epidemiologic identification and mechanistic investigation of early life environmental risk factors for eosinophilic esophagitis$696,693
R01 · FY2021 · ES · contact PI
Biostatistics and Clinical Research Core$189,734
P30 · FY2021 · DK · contact PI
Molecular and epigenetic predictors and mechanisms of treatment response to topical steroids in eosinophilic esophagitis$116,505
R21 · FY2021 · DK · contact PI
Molecular and epigenetic predictors and mechanisms of treatment response to topical steroids in eosinophilic esophagitis$324,595
R21 · FY2020 · DK · contact PI
Biostatistics and Clinical Research Core$191,717
P30 · FY2020 · DK · contact PI
Budesonide versus fluticasone for treatment of eosinophilic esophagitis$330,600
R01 · FY2018 · DK · contact PI
Budesonide versus fluticasone for treatment of eosinophilic esophagitis$330,600
R01 · FY2017 · DK · contact PI
Budesonide versus fluticasone for treatment of eosinophilic esophagitis$330,600
R01 · FY2016 · DK · contact PI
Budesonide versus fluticasone for treatment of eosinophilic esophagitis$330,600
R01 · FY2015 · DK · contact PI
Budesonide versus fluticasone for treatment of eosinophilic esophagitis$330,600
R01 · FY2014 · DK · contact PI
Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis$180,411
K23 · FY2013 · DK · contact PI
Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis$180,566
K23 · FY2012 · DK · contact PI
Risk Factors and Biomarkers for Diagnosis & Treatment of Eosinophilic Esophagitis$180,310
K23 · FY2011 · DK · contact PI